User profiles for Swayamjeet Satapathy
 | Swayamjeet SatapathySenior Resident, Department of Nuclear Medicine, All India Institute of Medical Sciences … Verified email at aiims.edu Cited by 574 |
Evolving role of 225Ac-PSMA radioligand therapy in metastatic castration-resistant prostate cancer—a systematic review and meta-analysis
Background Targeted radionuclide therapy with Actinium-225-labeled prostate-specific
membrane antigen ligands ( 225 Ac-PSMA) has emerged as a promising treatment modality in …
membrane antigen ligands ( 225 Ac-PSMA) has emerged as a promising treatment modality in …
Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta‐analysis
Objective Inoperable and metastatic pheochromocytomas and paragangliomas (PPGLs)
present a therapeutic challenge with current treatment options being limited to radiolabelled …
present a therapeutic challenge with current treatment options being limited to radiolabelled …
Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis
Please see the Editorial Comment by Devaki Shilpa Sudha Surasi discussing this article.
Please see the Author Video associated with this article. BACKGROUND. Early diagnosis is …
Please see the Author Video associated with this article. BACKGROUND. Early diagnosis is …
[HTML][HTML] 177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority …
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant
prostate cancer: a randomized, controlled, phase 2 non-inferiority trial | European Journal of …
prostate cancer: a randomized, controlled, phase 2 non-inferiority trial | European Journal of …
Visceral metastases as predictors of response and survival outcomes in patients of castration-resistant prostate cancer treated with 177Lu-labeled prostate-specific …
Background The presence of visceral metastases is associated with poor prognosis in patients
of metastatic castration-resistant prostate cancer (mCRPC) treated with hormonal therapy …
of metastatic castration-resistant prostate cancer (mCRPC) treated with hormonal therapy …
Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial
S Satapathy, D Bandyopadhyay, BK Patro… - … therapies in medicine, 2020 - Elsevier
Objective This study was conducted to investigate and compare the effects of add-on folic acid
and vitamin B12 supplementation on glycaemic control, insulin resistance and serum lipid …
and vitamin B12 supplementation on glycaemic control, insulin resistance and serum lipid …
177Lu-DOTATATE peptide receptor radionuclide therapy versus Everolimus in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
S Satapathy, BR Mittal - Nuclear medicine communications, 2019 - journals.lww.com
Objective Advanced pancreatic neuroendocrine tumors (pNETs) present a therapeutic
challenge with targeted therapies like Everolimus and 177 Lu-DOTATATE peptide receptor …
challenge with targeted therapies like Everolimus and 177 Lu-DOTATATE peptide receptor …
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
…, S Ballal, M Martin, F Roesch, S Satapathy… - European Journal of …, 2024 - Springer
Purpose The upregulation of fibroblast activation protein (FAP) expression has been observed
in various cancers, including metastatic breast carcinoma, prompting research into small …
in various cancers, including metastatic breast carcinoma, prompting research into small …
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant …
S Ballal, MP Yadav, S Satapathy, S Raju… - European Journal of …, 2023 - Springer
Purpose Despite the existence of various treatment options, the prognosis for patients with
metastatic castration-resistant prostate cancer (mCRPC) remains unfavorable. One potential …
metastatic castration-resistant prostate cancer (mCRPC) remains unfavorable. One potential …
Genomic landscape of sporadic pediatric differentiated thyroid cancers: a systematic review and meta-analysis
S Satapathy, C Bal - Journal of Pediatric Endocrinology and …, 2022 - degruyter.com
Objectives Differentiated thyroid cancers (DTCs) in the paediatric population differ from that
of their adult counterparts in terms of clinicopathological characteristics and treatment …
of their adult counterparts in terms of clinicopathological characteristics and treatment …